Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Liraglutide as an Adjunct to Dietary Intervention on Body Weight, Body Composition, Ectopic Lipid Accumulation and Insulin Sensitivity in Subjects With Overweight or Obesity Without Diabetes

NCT07913685 is registered in ClinicalTrials.gov with Medical University of Bialystok as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07913685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Liraglutide as an Adjunct to Dietary Intervention on Body Weight, Body Composition, Ectopic Lipid Accumulation and Insulin Sensitivity in Subjects With Overweight or Obesity Without Diabetes
Lead sponsor
Medical University of Bialystok
Phase
Phase 4
Overall status
Completed
Start date
April 5, 2023
Completion date
January 19, 2026
Enrollment
83 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity & overweight

Arms

As registered; 2 arms.

  • Liraglutide+low-calorie diet ExperimentalLow-calorie diet with dietician's monitoring, liraglutide

    Liraglutide administered once daily s.c. + low-calorie diet Duration: 12 weeks

  • Low-calorie diet Active comparatorLow-calorie diet with dietician's monitoring

    Low-calorie diet Duration: 12 weeks

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Change in body weight (kg) Week 12

    Observed change in body weight from baseline to week 12 in the group treated with liraglutide+LCD compared to dietary intervention alone.

Lead sponsor's other trials

Medical University of Bialystok, most recent start first.

Similar trials

Same condition (Weight Loss) and phase, most recent start first.